Thursday, November 06, 2025 1:59:23 PM
jesster,
The focus word in my post is " reading". You do not need to be a member/sign up to read ihub but it is required if you chose to post which I never felt compelled to do until recently. I had previously chosen to stay silent simply given my lack of knowledge in the bio arena. I noted your previous disdain for my first post which I deem understandable. The very first response was simply a spoof type reply to Maverick who I thought may be implying hostile take over in his mysterious quips. Admittingly, and given the longevity of this approval process, I've become more fearful of a takeover occurring hence my poison pill question. Seen enough in the markets throughout the years to know that any things possible and sometimes the crooks win. With that said, I haven't been here long enough ( 5 months) to note any conversation related to the safe guarding of our company and typically such things are not easily found. I stay away from the noise but like to be as informed as possible. The content in some post here are exceptional in comparison to others i have monitored. for that, I am grateful.
The focus word in my post is " reading". You do not need to be a member/sign up to read ihub but it is required if you chose to post which I never felt compelled to do until recently. I had previously chosen to stay silent simply given my lack of knowledge in the bio arena. I noted your previous disdain for my first post which I deem understandable. The very first response was simply a spoof type reply to Maverick who I thought may be implying hostile take over in his mysterious quips. Admittingly, and given the longevity of this approval process, I've become more fearful of a takeover occurring hence my poison pill question. Seen enough in the markets throughout the years to know that any things possible and sometimes the crooks win. With that said, I haven't been here long enough ( 5 months) to note any conversation related to the safe guarding of our company and typically such things are not easily found. I stay away from the noise but like to be as informed as possible. The content in some post here are exceptional in comparison to others i have monitored. for that, I am grateful.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
